Skip to main content
RxCopaysGet started

Diffuse Large B-cell Lymphoma

Rare

Cancer

Diffuse Large B-cell Lymphoma is treated with 8 medications in our database, including CYCLOPHOSPHAMIDE, POLIVY, Columvi, Rituxan Hycela, MONJUVI, and 3 more. 5 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Baxter, Genentech, Incyte, ADC Therapeutics, Genmab and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Diffuse Large B-cell Lymphoma treatment below.

What help exists for Diffuse Large B-cell Lymphoma

11

drugs indexed

6

with copay cards

6

with patient assistance

20

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Diffuse Large B-cell Lymphoma

11 total

🎟 = copay card · 💙 = patient assistance program

Prior authorization patterns for Diffuse Large B-cell Lymphoma drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

—

Medicare Part D

———

Showing 10 of 12 PA rules for Diffuse Large B-cell Lymphoma drugs. View individual drug pages for complete PA detail.

Grants for Diffuse Large B-cell Lymphoma patients

30 total · 20 open

Diffuse Large B-cell Lymphoma is a rare disease — more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare →